Article thumbnail
Location of Repository

First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease

By James Ferrero, Leslie Williams, Heather Stella, Kate Leitermann, Alvydas Mikulskis, John O'Gorman and Jeff Sevigny
Publisher: Elsevier BV
Year: 2016
DOI identifier: 10.1016/j.trci.2016.06.002
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doi.org/10.1016/j.trci... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.